MUTATIONS IN STEROID 21-HYDROXYLASE (CYP21)

被引:102
作者
WHITE, PC
TUSIELUNA, MT
NEW, MI
SPEISER, PW
机构
[1] CORNELL UNIV,COLL CHEM,DIV PEDIAT ENDOCRINOL,NEW YORK,NY 10021
[2] N SHORE UNIV HOSP,DIV PEDIAT ENDOCRINOL,MANHASSET,NY 11030
关键词
CYTOCHROME P450; STEROID; 21-HYDROXYLASE; CONGENITAL ADRENAL HYPERPLASIA;
D O I
10.1002/humu.1380030408
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The inherited inability to synthesize cortisol is termed congenital adrenal hyperplasia. More than 90% of cases are caused by 21-hydroxylase deficiency. This syndrome is characterized by sips of androgen excess and often mineralocorticoid deficiency. Steroid 21-hydroxylase (P450c21) is a microsomal enzyme expressed in the adrenal gland that catalyzes conversion of 17-hydroxyprogesterone and progesterone to 11-deoxycortisol and deoxycorticosterone respectively. In man, this enzyme is encoded by the CYP21 (CYP21B) gene which is located in the HLA major histocompatibility complex along with a pseudogene, CYP21P (CYP21A). Mutations in CYP21 causing congenital adrenal hyperplasia are almost all generated by recombinations between CYP21 and CYP21P. These recombinations either delete CYP21 or transfer deleterious mutations from CYP21P to CYP21, a process termed apparent gene conversion. The degree of enzymatic compromise caused by each mutation is correlated with the clinical severity of the deficiency observed in patients carrying that mutation. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:373 / 378
页数:6
相关论文
共 42 条
[1]   MUTATION IN THE CYP21B GENE (ILE-172-]ASN) CAUSES STEROID 21-HYDROXYLASE DEFICIENCY [J].
AMOR, M ;
PARKER, KL ;
GLOBERMAN, H ;
NEW, MI ;
WHITE, PC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (05) :1600-1604
[3]  
BRISTOW J, 1993, J BIOL CHEM, V268, P12919
[4]   TENASCIN-X - A NOVEL EXTRACELLULAR-MATRIX PROTEIN ENCODED BY THE HUMAN XB GENE OVERLAPPING P450C21B [J].
BRISTOW, J ;
TEE, MK ;
GITELMAN, SE ;
MELLON, SH ;
MILLER, WL .
JOURNAL OF CELL BIOLOGY, 1993, 122 (01) :265-278
[5]   MAPPING OF STEROID 21-HYDROXYLASE GENES ADJACENT TO COMPLEMENT COMPONENT C-4 GENES IN HLA, THE MAJOR HISTOCOMPATIBILITY COMPLEX IN MAN [J].
CARROLL, MC ;
CAMPBELL, RD ;
PORTER, RR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (02) :521-525
[6]  
CHIOU SH, 1990, J BIOL CHEM, V265, P3549
[7]   PULSED FIELD GEL-ELECTROPHORESIS IDENTIFIES A HIGH DEGREE OF VARIABILITY IN THE NUMBER OF TANDEM 21-HYDROXYLASE AND COMPLEMENT C-4 GENE REPEATS IN 21-HYDROXYLASE DEFICIENCY HAPLOTYPES [J].
COLLIER, S ;
SINNOTT, PJ ;
DYER, PA ;
PRICE, DA ;
HARRIS, R ;
STRACHAN, T .
EMBO JOURNAL, 1989, 8 (05) :1393-1402
[8]   A DENOVO PATHOLOGICAL POINT MUTATION AT THE 21-HYDROXYLASE LOCUS - IMPLICATIONS FOR GENE CONVERSION IN THE HUMAN GENOME [J].
COLLIER, S ;
TASSABEHJI, M ;
STRACHAN, T .
NATURE GENETICS, 1993, 3 (03) :260-265
[9]   PRENATAL TREATMENT IN CONGENITAL ADRENAL-HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY - UP-DATE 88 OF THE FRENCH MULTICENTRIC STUDY [J].
FOREST, MG ;
BETUEL, H ;
DAVID, M .
ENDOCRINE RESEARCH, 1989, 15 (1-2) :277-301
[10]   NONSENSE MUTATION CAUSING STEROID 21-HYDROXYLASE DEFICIENCY [J].
GLOBERMAN, H ;
AMOR, M ;
PARKER, KL ;
NEW, MI ;
WHITE, PC .
JOURNAL OF CLINICAL INVESTIGATION, 1988, 82 (01) :139-144